Related Experiment Video
Updated: May 19, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Biologic drugs in autoinflammatory syndromes
Roberta Caorsi1, Silvia Federici, Marco Gattorno
1Department of Paediatrics, University of Genoa, Pediatria II, Reumatologia, IRCCS G. Gaslini, Genoa, Italy.
Autoimmunity Reviews
|August 14, 2012
Summary
Biologic therapies, including anti-IL-1 and anti-TNF drugs, offer effective treatments for inherited autoinflammatory syndromes by targeting key inflammatory pathways. These targeted treatments can significantly reduce uncontrolled inflammation in conditions like cryopyrin-associated periodic syndromes.
Area of Science:
- Immunology
- Genetics
- Pharmacology
Background:
- Inherited autoinflammatory syndromes involve genetic mutations affecting innate immunity regulation.
- These conditions lead to uncontrolled inflammation and present significant clinical challenges.
- Understanding molecular pathways has revealed new therapeutic targets for these disorders.
Purpose of the Study:
- To provide a comprehensive overview of biologic therapies for inherited autoinflammatory syndromes.
- To highlight the efficacy of targeted cytokine blockade in managing these conditions.
- To review current treatment strategies and their impact on inflammatory response.
Main Methods:
- Review of existing literature on biologic treatments for autoinflammatory diseases.
- Analysis of clinical responses to targeted therapies such as anti-IL-1 and anti-TNF agents.
- Summarization of treatment outcomes in specific syndromes like CAPS, MKD, TRAPS, and DIRA.
Main Results:
- Anti-IL-1 therapies demonstrate dramatic efficacy in cryopyrin-associated periodic syndromes (CAPS).
- Biologics like anti-TNF and IL-1 blockers are crucial for managing mevalonate kinase deficiency and TNF-receptor associated periodic syndrome.
- Recombinant IL-1 receptor antagonist (anakinra) is the preferred treatment for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA).
Conclusions:
- Biologic agents represent a significant advancement in treating inherited autoinflammatory syndromes.
- Targeted blockade of specific cytokines offers a powerful strategy to control inflammation.
- Further research is needed for rare autoinflammatory diseases where anecdotal evidence guides treatment.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...